BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21084703)

  • 1. Is coronary artery calcification at the intersection of vitamin D and coronary artery disease?
    Dastani Z; Richards JB
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2329-30. PubMed ID: 21084703
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification.
    Shen H; Bielak LF; Ferguson JF; Streeten EA; Yerges-Armstrong LM; Liu J; Post W; O'Connell JR; Hixson JE; Kardia SL; Sun YV; Jhun MA; Wang X; Mehta NN; Li M; Koller DL; Hakonarson H; Keating BJ; Rader DJ; Shuldiner AR; Peyser PA; Reilly MP; Mitchell BD
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2648-54. PubMed ID: 20847308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
    Simon KC; Munger KL; Xing Yang ; Ascherio A
    Mult Scler; 2010 Feb; 16(2):133-8. PubMed ID: 20007432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.
    Kelly JL; Drake MT; Fredericksen ZS; Asmann YW; Liebow M; Shanafelt TD; Feldman AL; Ansell SM; Macon WR; Herr MM; Wang AH; Nowakowski GS; Call TG; Habermann TM; Slager SL; Witzig TE; Cerhan JR
    Cancer Causes Control; 2012 Jul; 23(7):1017-29. PubMed ID: 22544453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.
    Penna-Martinez M; Ramos-Lopez E; Stern J; Kahles H; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
    Thyroid; 2012 Jul; 22(7):709-16. PubMed ID: 22690899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D pathway gene variants and prostate cancer prognosis.
    Holt SK; Kwon EM; Koopmeiners JS; Lin DW; Feng Z; Ostrander EA; Peters U; Stanford JL
    Prostate; 2010 Sep; 70(13):1448-60. PubMed ID: 20687218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
    Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.
    Levin GP; Robinson-Cohen C; de Boer IH; Houston DK; Lohman K; Liu Y; Kritchevsky SB; Cauley JA; Tanaka T; Ferrucci L; Bandinelli S; Patel KV; Hagström E; Michaëlsson K; Melhus H; Wang T; Wolf M; Psaty BM; Siscovick D; Kestenbaum B
    JAMA; 2012 Nov; 308(18):1898-905. PubMed ID: 23150009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D pathway gene variants and prostate cancer risk.
    Holt SK; Kwon EM; Peters U; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1929-33. PubMed ID: 19454612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
    Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
    Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
    Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
    Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism.
    Okuda K; Usui E; Ohyama Y
    J Lipid Res; 1995 Aug; 36(8):1641-52. PubMed ID: 7595086
    [No Abstract]   [Full Text] [Related]  

  • 13. No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.
    Schäfer A; Emmert S; Kruppa J; Schubert S; Tzvetkov M; Mössner R; Reich K; Berking C; Volkenandt M; Pföhler C; Schön MP; Vogt T; König IR; Reichrath J
    Arch Dermatol Res; 2012 Jul; 304(5):353-61. PubMed ID: 22576141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
    Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
    Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
    Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases.
    Kiani A; Mohamadi-Nori E; Vaisi-Raygani A; Tanhapour M; Elahi-Rad S; Bahrehmand F; Rahimi Z; Pourmotabbed T
    Mol Biol Rep; 2019 Oct; 46(5):5225-5236. PubMed ID: 31359379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
    Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
    J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.